Some research has demonstrated systemic anti-inflammatory and neuroprotective benefits in patients with diabetes, but specific data regarding risk for age-related macular degeneration (AMD) in those without the disease is minimal
The variety of conditions depends only on the patients well-being in general, as well as on their weakest spots (for example, individuals with vision problems often suffer from diabetic retinopathy, and those who are overweight may face higher risks of strokes, heart attacks, and other heart-related issues)
Specifically, Rybelsus (oral semaglutide) has been shown to lower A1C by about 1.0% to 1.5%, while Foundayo (orforglipron) reported average A1C reductions ranging from about 1.2% to 1.7% depending on the dose
While some improvements were noted, they werent statistically consistent
Magnesium supplements (200400mg daily) serve double duty: they support relaxation and promote bowel regularity
Think of the mitochondria as the engine of all cellular functions